

Recurring brain tumor growth is halted with new drug
May 18, 2022
Northwestern discoveries pave the way for more effective screening, better drug delivery and treatment as well as extended survival rates
New biomarker discovery could prolong lives of estimated 20% to 30% of these malignant brain tumor patients
Amy Heimberger is one of the key leaders of the Lurie Cancer Center